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ABSTRACT
Background: Differential gene expression in CD3+ T cells from allergic patients stimulated with allergen will
provide important information on the responses of T cells．
Methods: After stimulation of peripheral blood mononuclear cells (PBMCs) with mite extracts, levels of gene
transcription were examined in CD3+ T cells from allergic patients．
Results: Stimulation of PBMCs from mite specific IgE positive subjects resulted in specific upregulation of
MAL transcription levels that was mediated by IL-4 secretion. The MAL protein in IL-4 stimulated primary T
cells preferentially localized in glycolipid-enriched membrane (GEM) microdomains. When MAL was exoge-
nously expressed in primary T cells, CD3ζ was concomitantly enriched, along with the expression of MAL, in
GEM microdomains．
Conclusions: GEMs are important for the formation and stabilization of TCR signaling complexes. Therefore,
MAL may play a role in the formation of GEMs in activated T cells and the high expression of MAL may contrib-
ute to Th2 immune response．
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INTRODUCTION
MAL, a proteolipid present in the glycolipid-enriched
membrane (GEM) microdomain, has been reported
to be expressed in T cells of the immune system, the
central nervous system, gray mater of the cerebral
cortex, and the thyroid gland.1,2MAL, cloned from T
cells, is expressed in the intermediate and late stages
of T cell differentiation and is thought to play a spe-
cific role in the differentiation process.3 In polarized
epithelial cells, MAL is a component of the raft ma-
chinery for apical sorting of both membrane and sec-
retary proteins . 4,5 As shown by co-immunopreci-
pitation studies, MAL associates with GPI anchored
proteins (CD59, CD55, and CD48) as well as Src-like
tyrosine kinases (Lck and Fyn).6 Such associations
point to a role for MAL as a linker protein for GPI-
anchored protein and Src-like kinase mediated events
that occur in GEM microdomains. However little is
known about MAL expression during immune or al-
lergic reactions．
After cellular presentation of antigen, the T cells
produce cytokines to regulate the immune response.
Th2 cells producing IL-4, IL-5 and IL-13 are involved
in the development of allergic diseases.7,8 Any gene
showing altered expression levels in T cells during
the allergic response could be assumed to have a key
role. Mite antigen is a typical allergen that precipi-
tates diseases such as atopic dermatitis , allergic
asthma and perennial allergic rhinitis.
One technique for studying the allergic reaction in
vitro is to stimulate peripheral blood mononuclear
cells (PBMCs) with the mite extracts and measure
the transcriptional levels of genes in T cells. Using
transcription analysis by oligonucleotide microarray
technique, we found that mRNA levels of MAL in-
creased in CD3+ cells in an asthmatic patient after
stimulation of PBMCs with mite extracts. To study
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the possible role of MAL expression in allergic dis-
eases, we confirmed the upregulation of MAL mRNA
in a number of atopic subjects. We further examined
the mechanism of upregulation of MAL, localization
of MAL protein in GEM microdomains, and expres-
sion levels ofMAL in Th2-polarized cells. We will dis-
cuss the relevance of high expression of MAL mRNA
in atopic individuals．
METHODS
STUDY POPULATION AND SAMPLE COLLEC-
TION
Blood samples were collected from both healthy sub-
jects and patients with atopic dermatitis (AD) andor
asthma (AS). Patients with AD were diagnosed ac-
cording to the criteria of Hanifin.9 Diagnosis of AS
was based on the asthma prevention and manage-
ment guidelines . 10 Serum IgE levels specific for
house dust mite Dermatophagoides pteronyssinus (Dp
IgE) were determined using enzyme-linked immuno-
sorbent assay kits (CAP IgE FEIA, Pharmacia Upjohn
Inc.). For real time PCR quantification of mRNA in
mite-extract stimulated PBMCs, a total of 37 samples
were obtained from 8 Dp IgE (−) healthy donors, 10
Dp IgE (+) healthy donors, 2 Dp IgE (−) patients and
17 Dp IgE (+) patients. The 2 Dp IgE (−) subjects in-
cluded both an AS and AD subject. The 17 Dp IgE (+)
cohort consisted of 7 AS, 5 AD, and 5 subjects that
suffered from both AS and AD. The AD patients were
treated with topical glucocorticoid ointments . A
milder steroid (mainly hydrocortisone acetate) was
used for treating the face and a stronger steroid
(mainly dexamethasone valerate) for the body. None
of the AD patients had been treated with systemic
glucocorticoids. The moderate and severe asthmatics
were treated with inhalational glucocorticoids (beclo-
methasone propionate). During periods of exacerba-
tion, inhaled β2 agonists were added to the regimen.
Glucocorticoids were not used for the mild asthmat-
ics, but inhaled β2 agonists were used as needed.
None of the asthmatics had been routinely treated
with systemic glucocorticoids . This study was ap-
proved by the research ethics committee of the Na-
tional Research Institute for Child Health and Devel-
opment. Written informed consent to participate in
the study was obtained from volunteers after provid-
ing them with detailed information about the study
and subjects’ rights．
LEUKOCYTE SUBSET PREPARTION
PBMCs were prepared as described previously . 11
CD3+ cells were isolated from PBMCs using a mag-
netic cell sorter (CD3 Micro Beads and MS+ col-
umns, Miltenyi Biotec GmbH, Bergisch Gladbach,
Germany). The percentage of CD3+ cells in column
yields was > 97%. CD16- cells (eosinophils), obtained
from the sedimentary granulocyte fraction of the
Ficoll-Hypaque gradients, were isolated by negative
selection using a magnetic cell sorter. The percent-
age yield of eosinophils was > 97% . CD14 + cells
(monocytes) were prepared from cells remaining af-
ter separation of CD3+ cells. The cells remaining af-
ter separation of CD14+ cells were used as a source
of B cells. CD16+ granulocytes remaining after sepa-
ration of CD16- cells were the source for neutrophils.
CD 8 + cells were prepared from PBMCs of a
healthy volunteer by magnetic sorting. CD4+ cells
were isolated from cells remaining after separation of
CD 8 + cells using CD 4 multisort microbeads
(Miltenyi Biotec). After removing the magnetic parti-
cles from the CD4+ cells, CD45RA+ cells were iso-
lated. CD45RO+ cells were prepared from the cells
remaining after separation of CD45RA+ cells．
REAL TIME QUANTITATIVE RT-PCR
Real time quantitative RT-PCR for quantification of
gene expression was performed using an ABI PRISM
7700 Sequence Detection System (PE Applied Bio-
systems , USA) as described previously . 11 DNase-
treated total RNAs were mixed with random primer
( Invitrogen Co . , Carlsbad , USA) , and first strand
cDNAs were synthesized. The primer sequences for
MAL ( accession No . X 76223 ) were
AAAAGCCCTGCCCTGTTGCT ( forward ) ,
CCCCGAACAAGAAGGTCCCC ( reverse ) , and the
probe sequence was
TGCTGTGTTTACTCTCCCGTGTGCC . The primer
sequences for IL-4 receptor α ( IL-4Rα , accession
No.X52425) were CGACTTGTGAACGAGTTGTTGG
( forward ) , TTCAGTGAGACAGAGGCAGGTG ( re-
verse ) , and the probe sequence was
TGTTGTAACTGCCCAAGGCATGTTTTGC . Levels
of β-actin mRNA were used as an internal standard
and quantified in each sample．
MICROARRAY ANALYSIS OF MITE ANTIGEN
STIMULATED LEUKOCYTE
Approximately 100 ml of peripheral blood was col-
lected from a single patient with allergic chronic
bronchial asthma and a single normal healthy subject
for PBMC preparation . PBMCs were cultured in
RPMI1640 supplemented with 10% fetal calf serum,
penicillin(100 unitml)and streptomycin (100 μgml),
using humidified conditions and 5% CO2. Cultures
were stimulated with mite extracts (5 μgml each
mite extract from D. pteronyssinus and D . farinae,
COSMO BIO, Tokyo, Japan) both with and without
dexamethasone (100 nM). At 12 h and 40 h after
stimulation, CD3+ cells were isolated and total RNA
was extracted. Gene expression was analyzed using
an oligonucleotide array (GeneChip HuGene FL Ar-
ray , Affymetrix , Santa Clara , CA, USA). It is well
known that the majority of individuals who are posi-
tive for specific IgE to D. pteronyssinus (Dp) are also
positive for specific IgE to D. farinae (Df). Therefore
subjects were not tested for Df IgE levels, but a mix-
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ture of both Dp and Df extracts was used to assure
optimal responses . In a preliminary experiment ,
PBMCs from allergic patients were stimulated with
various concentrations of mite extract mixtures and
IL-5 levels in the supernatants were determined .
Stimulation with the mixture containing 5 μgml of
each extract resulted in the maximum IL-5 secretion
and this concentration was used for all experiments.
Because glucocorticoids are known to suppress tran-
scriptional upregulation of various genes in stimu-
lated leukocytes,12 dexamethasone was used to evalu-
ate glucocorticoid susceptibility of gene expression.
QUANTITATIVE PCR OF MITE ANTIGEN STIMU-
LATED LEUKOCYTE
PBMCs were prepared from 10 ml blood samples .
Approximately 2 × 106 PBMCs were stimulated in 1
ml of RPMI1640 supplemented with 10% fetal calf se-
rum in the presence of mite extracts both with and
without dexamethasone. After 24 h, the cells were
collected, washed with PBS, and RNA was extracted.
IL-4 in the culture supernatants was quantified by
ELISA (Quantikine HS Human IL-4 ELISA Kit, R & D
Systems, Inc., Minneapolis, USA). For some experi-
ments neutralizing IL-4 antibody (200 ngml, purified
rat anti-human IL-4, PharMingen, San Diego, USA)
was used. After RNA extraction, gene expression was
quantified using real time PCR．
CYTOKINE STIMULATION OF PRIMARY T
CELLS
CD3+ cells were stimulated by culture on plates
coated with CD3 monoclonal antibody (10 μgml, Or-
thoclone OKT3, Ortho Biotech, South Raritan, USA)
to induce cell growth. The cells were diluted to a den-
sity of 5 × 105 cellsml and cultured for 5 days in
RPMI 1640 supplemented with 5% FCS , 2 mM L-
glutamine, 1mM sodium pyruvate, penicillin (100 U
ml ), streptomycin (100 μgml ) and IL-2 (200 Uml,
Imunace, Shionogi Pharmaceutical , Osaka, Japan) .
The expanded T cells were then diluted in the same
medium to a density of 5 × 105 cellsml for an addi-
tional 3 days of culture on a non-surface treated plate.
The final culture of cells was washed and cultured at
a density of 1 × 106 cellsml in IL-2 free medium sup-
plemented with different cytokines. Cytokines were
used at the following concentration ; 2 ngml of IL-4
(Pharmingen), 2 ngml of IL-12 (Intergen), 200 ng
ml of IFN-γ (Sigma, Saint Louis, USA), and 100 IUml
of IFN-α (Sigma)．
CLONING AND SUBCELLULAR LOCALIZATION
OF GFP-MAL FUSION PROTEIN
MAL gene was amplified using a UniGene clone plas-
mid (AW25038, NCBI) as a template. The amplified
fragment was cloned into a multiple cloning site of
pEGFP-C3 (Clontech, Palo Alto, USA) to construct a
pEGFPMAL1 plasmid. The plasmid DNA was trans-
fected to Jurkat cells, and a stable transformed cell
line, GFPMAL1, was obtained. For the induction of
GFP-MAL fusion protein , GFPMAL 1 cells were
stimulated with phorbol 12-myristate 13-acetate
(PMA, 25 ngml ) and ionomycin (1 μgml )．
POLARIZATION OF CORD BLOOD MONONU-
CLEAR CELLS
Umbilical cord blood was collected from healthy full-
term neonates immediately after delivery. Mononu-
clear cells were isolated by Ficoll density gradient
centrifugation13 and stimulated with 2 ugml PHA
(Difco, Detroit, USA) in the presence of 2 ngml IL-
12 and 200 ngml neutralizing anti-IL-4 for Th1 polari-
zation or 2 ngml IL-4 and 5 ngml neutralizing anti-
IL-12 (Genzyme, Cambridge, USA) for Th2 polariza-
tion. Cells were washed once on day 3 and expanded
until day 10 in RPMI1640 medium supplemented with
10% FCS containing 4 ngml IL-2 for Th1 polarization
or 4 ngml IL-2 and 2 ngml IL-4 for Th2 polarizing
condition . During expansion , cell densities were
maintained at a concentration that did not exceed 2 ×
106 cellsml by diluting the culture with the respec-
tive medium. When stimulated with PMA and iono-
mycin, the Th2 polarized cells, but not Th1 polarized
cells, secreted IL-4 and IL-5. The Th1 polarized cells
produced higher levels of IFN-γ than Th2 cells (data
not shown)．
RETROVIRAL MEDIATED TRANSDUCTION OF
MAL IN T CELLS
For the expression of exogenous MAL in human pri-
mary T cells, the retroviral transduction system was
modified.14-16 Briefly , MAL cDNA was amplified by
PCR and cloned into the EcoRI cloning site of pBabe-
CLXIP to construct a MAL expression pBabeMALs
plasmid. Viral supernatant was prepared by transfect-
ing 293-EBNA packaging cells with plasmid DNAs of
PCLA-ampho, pCLAG and pBabeMALs using two kits
(RetroMax System, Imgenex, San Diego, USA and
TransIT-LTI). CD3+ cells prepared from PBMC were
cultured and maintained for 3 days in a CD3 monoclo-
nal antibody coated plate with the medium containing
200 uml of IL-2. On day 3, the cells were transduced
with retrovirus for 8 hours on a retronectin (Takara
Shuzo, Kyoto, Japan) coated plate . The cells were
harvested and cultured for expansion in fresh me-
dium. On day 6, the cells were transferred to the me-
dium containing 0.2 μgml of puromycin to select
transduced cells. On day 21, cells were harvested and
used for GEM protein analysis.
PREPARATION OF GEM MICRODOMAINS AND
WESTERN BLOT ANALYSIS
GEMmicrodomains were isolated by standard proce-
dures described by Fernando Martin-Belmonte et al.4
with slight modifications. Approximately 1 × 108 har-
vested T cells were washed with PBS and suspended
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in 108 solution (150 mM of NaCl, 10 mM of Tris HCl
pH 7.4, 5 mM of EDTA, 0.2% Triton X100) containing
protease inhibitors (1 mM of PMSF, 18 μgml of
aprotinin , 50 μgml of leupeptin , 1 mM of ben-
zamidine and 0.7 μgml of pepstatin). The cell sus-
pension was incubated for 30 min at 4℃ with periodic
agitation and then homogenized by passing the sam-
ple through a 22-gauge needle. The extract was ad-
justed to contain 42.5% sucrose in a final volume of 3
ml, placed at the bottom of a centrifuge tube and
overlaid with 6 ml of 35% sucrose and 4 ml of 5% su-
crose. The stepwise gradients were centrifuged for 16
h at 38,000 rpm at 4℃ in a RPS40T rotor (Hitachi Koki
Co., Tokyo, Japan). Fractions of 1 ml were harvested
from the top of the tube and analyzed by im-
munoblots. Twenty μl per lane of each fraction was
used for SDS polyacrylamide gel electrophoresis .
Western blot analysis was performed as described
previously.17 Various antibodies were used as probes.
Based on the aa sequence of human MAL,3 rabbit
polyclonal antibody was raised against MAL N-
terminal peptide (MAPAAATGGSTLP) and then af-
finity purified. The antibody recognized recombinant
MAL protein as well as endogenous MAL protein in
raft fractions (data not shown). Rabbit LAT polyclonal
antibody (Upstate Biotechnology, Lake Placid, USA),
mouse CD 3 ζ monoclonal antibody ( Santa Cruz
Biotechnology, Inc., Santa Cruz, USA) and cholera
toxin B subunit peroxidase conjugate (Sigma) were
used．
STATISTICAL ANALYSIS
Data were analyzed for significance by a repeated
measure ANOVA and Spearman’s correlation coeffi-
cients by rank were obtained using StatView J-5.0
computer software (SAS Institute Inc., USA)．
RESULTS
CORRELATION OF MAL EXPRESSION LEVELS
WITH ALLERGIC DISEASE AND IL-4 RECEPTOR
EXPRESSION LEVELS
To identify allergic disease-associated genes, PBMCs
from both an atopic patient and a healthy subject
were stimulated with the mite extracts and the ex-
pression profiles in the isolated CD3+ T cells were
analyzed using an oligonucleotide array. The expres-
sion of MAL gene exon 4 (GeneBank accession No.
X76223) was higher in the atopic patient than in the
healthy subject at both 12 and 40 h after the antigen
stimulation . The increase in MAL expression was
suppressed in the presence of dexamethasone (data
not shown)．
To confirm the results of the microarray experi-
ments , PBMCs from patients and healthy donors
were stimulated with the mite extracts and the MAL
expression levels were quantified by PCR. We also
analyzed mRNA levels of IL-4 Rα as an allergic
disease-related gene. The primers and probe forMAL
were designed based on the MAL sequence regis-
tered on the chip and those for IL-4Rα were designed
based on the coding sequence of the gene. Changes
in the MAL expression levels related to the presence
or absence of the mite antigen stimulation are shown
in Figure 1A. A majority of patients were positive for
the Dp IgE antibody, indicating allergy to the mite an-
tigen. The MAL levels without stimulation were simi-
lar ( approximately 1,000 copyngRNA ) in the 4
groups (Dp IgE (−) healthy donors , Dp IgE (+ )
healthy donors, Dp IgE (−) patients and Dp IgE (+)
patients ) . With mite extract stimulation the levels
were increased an average of 2.4 times in the Dp IgE
(+) healthy donors and 3.3 times in the Dp IgE (+) pa-
tients. In contrast, the increase was less in the Dp IgE
(−) healthy donors (1.4) and Dp IgE (−) patients
(1.0). Repeated ANOVA analyses showed a signifi-
cant difference ( p < 0.01) in MAL level elevation
among the 4 groups. Post hoc tests showed that the
MAL levels tended to be more elevated ( p = 0.075)
in the Dp IgE (+) healthy donors than in the Dp IgE
(−) healthy donors and that the MAL levels were sig-
nificantly ( p < 0.05) elevated in the Dp IgE (+) pa-
tients when compared to the Dp IgE (−) healthy do-
nors. When all samples were divided into two groups
(the Dp IgE (+) group and the Dp IgE (−) group) the
MAL levels were significantly elevated in the Dp IgE
(+) group ( p < 0.05). The expression profile of IL-4
Rα was quite similar to that of MAL. IL-4Rα lev-
els were significantly ( p < 0.05) elevated in the Dp
IgE (+) healthy donors when compared to the Dp IgE
(−) healthy donors and significantly ( p < 0.01) ele-
vated in the Dp IgE (+) patients when compared to
the Dp IgE (−) healthy donors. The IL-4Rα levels
were also significantly elevated in the Dp IgE (+)
group ( p < 0.01) compared to the Dp IgE (−) group.
The change in expression levels of MAL between the
unstimulated and stimulated samples was tightly cor-
related with that of IL-4 Rα ( p = 0.94, p < 0.0001,
Fig. 1C ). Upregulation of both MAL and IL-4Rα
was completely inhibited in the presence of dex-
amethasone (data not shown). When the expression
levels in various subsets of peripheral blood leuko-
cytes were quantified , MAL was expressed at the
highest levels in CD3+ cells (Fig. 2A ). In the T cell
subsets , MAL was expressed at a higher level in
CD4+ cells than in CD8+ cells (Fig. 2B ) and at simi-
lar levels in CD4+CD45RA+ and CD4+CD45RO+ sub-
sets．
RELATIONSHIP OF IL-4 TO CONTROL OF IN-
DUCTION OFMAL
Next, we examined the mechanism ofMAL upregula-
tion in CD3+. In most mite specific IgE positive sub-
jects, IL-4 was detected after stimulation of cells with
mite extracts (Fig. 1B ). At the same time, the MAL
expression was also increased. To examine the in-
volvement of IL-4 in MAL upregulation, IL-4 secreted
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Fig. 1 Upregulation pf MAL mRNA and IL-4 levels in PBMCs stimulated with mite extracts. PBMCs from 
healthy (H) and patient (P) samples were cultured in the presence (Mite) or absence (Control) of mite extracts. 
Specific IgE positive (＋) and negative samples (－) are indicated. After 24 h, total RNAs were extracted from the 
cels and mRNA levels of MAL were examined by quantitative PCR (A). Concentrations of IL-4 secreted into the 
culture supernatant were determined by ELISA (B). Corelation between the changes in expression of both MAL 
and IL-4 receptor α after stimulation with mite extracts (C). 
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Fig. 2 High transcription levels of MAL in peripheral blood T cels. Peripheral 
blood leukocyte subsets were prepared from 5 healthy subjects and mRNA levels 
of MAL were examined by quantitative PCR. B: B cels, E: eosinophils, M: mono-
cytes, N: neutrophils and T: T cels (A). T cel subsets were prepared from a healthy 
subject and mRNA levels of MAL were examined (B).
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in the culture was neutralized by adding IL-4 mAb.
The upregulation ofMALmRNA by mite extracts was
totally attenuated in the presence of IL-4 mAb
(Fig. 3). Next, primary T cells were cultured in the
presence of various cytokines. During cultivation for
0―48 h, mRNA forMAL was induced after stimulation
with IL-4, but not with IL-12, IFN-γ, IFN-α (Fig. 4 ), or
IL-13 (data not shown). These results strongly sug-
gested that IL-4 is necessary for induction of MAL
mRNA.
EXPRESSION OF MAL PROTEIN IN GEM MICRO-
DOMAINS
Since MAL preferentially localizes in the GEM micro-
domains, we explored the possibility that the IL-4 in-
duced MAL plays a role in T cell GEM microdo-
mains . GFP-MAL protein was expressed in Jurkat
cells and the localization was examined. Accumula-
tion of GFP-MAL protein on the cell surface mem-
brane was observed (Fig. 5 ). We further examined
the localization of MAL in detergent insoluble GEM
microdomains. MAL protein levels in GEM fractions
were examined by Western blotting and detected
with polyclonal antibody to a MAL peptide (Fig. 6 ).
The MAL protein preferentially localized in GEM
fractions, and the protein level of MAL of IL-4 stimu-
lated CD3+ T cells was higher than that of non-
treated cells. In contrast, the level of LAT, a protein
marker for lipid rafts of T cells , 18 was unchanged
even after IL-4 stimulation．
EXPRESSION OF MAL IN T CELLS CULTURED
UNDER TH2 POLARINZING CONDITION
Since IL-4 occupies a critical role in the development
of Th2 cells, we compared the MAL levels between
Th1 and Th2 polarized cells that were derived from
cord blood mononuclear cells . No differences be-
tween Th1 and Th2 polarized cells were detected for
either mRNA levels (data not shown) or protein lev-
els in GEM microdomains (Fig. 7 )．
278 Allergology International Vol 54, No2, 2005 www.js-allergol.gr.jp
Nagata N et al.
Fig. 3 Involvement of IL-4 in upregulation of MAL by sti-
mulation with mite extracts. PBMCs from both alergic and 
healthy subjects were stimulated with mite extracts in either 
the presence or absence of IL-4 monoclonal antibody 
(mAb). Total RNAs were extracted and mRNA levels of 
MAL were examined by quantitative PCR. Data is shown 
from cultures stimulated with mite extracts (Mite), mite ex-
tracts in the presence of IL-4 mAb (Mite + IL-4 mAb), iso-
type antibody (Ab) (Mite + isotype Ab), unstimulated 
(Control), and IL-4 mAb alone (IL-4 mAb).
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Fig. 4 Upregulation of MAL mRNA by IL-4 in primary T 
cels. Primary CD3+ cels were stimulated with IL-4, IL-12, 
IFN-γ or IFN-α for various time periods. The cels were 
harvested and MAL mRNA was measured by quantitative 
PCR. 
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Fig. 5 Subcelular localization of GFP-MAL fusion protein 
at the cel surface membrane in Jurkat cels. A stable trans-
formant expressing GFP-MAL fusion protein was derived 
from Jurkat cels that were transfected with pEGFPMAL1.  
Protein expression was induced with PMA and ionomycin 
for 24 h and the cels were examined by fluorescent micro-
scopy. 
Fig. 6 Induction of MAL protein in GEM microdomains of 
primary T cels after stimulation with IL-4. CD3+ cels 
(1×108) that were expanded with anti-CD3 stimulation were 
incubated with 2 μg/ml of IL-4 for 24 h. The cels were har-
vested and GEM microdomains were prepared by sucrose 
density gradient centrifugation. MAL and LAT proteins were 
detected in the GEM fractions (No. 2, 3, 4 and 5) by West-
ern bloting. 
2 5 2 4Fraction 3 4 3 5
30 K
21.5 K
14.3 K
6.5 K
MAL
(16.7 kDa)
LAT
Control IL-4 stimulation
RECRUITMENT OF CD3ζ PROTEIN IN GEM AF-
TER FORCED EXPRESSION OF MAL
CD3ζ chain is crucial for T cell receptor mediated sig-
naling. Tyrosine phosphorylated CD3ζ translocates
to GEM microdomains upon T cell activation. 19 To
examine the effect of MAL on CD3ζ localization ,
MAL was exogenously expressed in human primary
T cells by retroviral transduction and the protein lev-
els of CD3ζ in GEM fractions were examined. The
protein levels of CD3ζ in GEM microdomains were
markedly increased coincidentally with MAL (Fig.8).
There were no significant changes in the levels of two
marker molecules, LAT and GM1 ganglioside. These
results suggest that the MAL protein plays a role in
recruiting CD3ζ into the GEM microdomains．
DISCUSSION
Our data showed that 1 ) MAL transcription levels
were upregulated specifically in CD3+ T cells when
PBMCs from Dp IgE (+) subjects were stimulated
with mite extracts 2) IL-4 secretion as a result of mite
antigen stimulation was critical for the upregulation
of MAL and 3) IL-4 stimulation of primary T cells re-
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Fig. 7 MAL protein levels in GEM microdomains of Th1 
polarized and Th2 polarized T cels. Cord blood mononu-
clear cels were cultured in Th1 or Th2 polarizing condition. 
The cels were harvested and GEM microdomains were pre-
pared by sucrose density gradient centrifugation. MAL and 
LAT proteins were detected in the GEM fractions (No. 4, 5, 
6 and 7) by Western bloting.
5 7
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4 7Fraction
MAL
(16.7 k)
LAT
Th1
condition
Th2
condition
4 6 5 6
Fig. 8 Enrichment of CD3ζ protein in GEM microdomains 
after forced expression of MAL in primary T cels. MAL was 
exogenously expressed in human primary T cels by retrovi-
ral transduction. The transduced cels (1×108) were har-
vested and the GEM microdomains were prepared. The 
protein levels of MAL, CD3ζ and LAT in GEM fractions (No. 
4, 5 and 6) were examined by Western bloting. The levels 
of GM1 were detected using cholera toxin B subunit-peroxi-
dase conjugate. 
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sulted in enrichment of MAL protein in GEM micro-
domains．
The IL-4 levels that were secreted in supernatant
after stimulation of PBMCs with mite extract were as
low as sub- picograms per ml to several picograms
per ml. Such low levels probably reflected the limited
presence of a T cell subpopulation that recognized
mite antigen as well as the IL-4 consumption by IL-4R
bearing cells in PBMCs.20
A high positive correlation of the mRNA expres-
sion profiles between MAL and IL-4Rα was observed
in our study. In addition the upregulation with mite-
extract stimulation was suppressed in the presence of
dexamethasone for both MAL and IL-4 Rα. These
findings suggest that the regulatory mechanisms for
transcription may be similar for these two genes. IL-4
exerts its biological effects by binding to the IL-4R
complex and upregulates the expression of the hu-
man, as well as mouse, IL-4Rα chain in an autocrine
manner21 through STAT6 dependent signaling . 22-24
From our data-base search of the MAL genome se-
quence, a number of consensus sequences for STAT6
(TTCNNNNGAA) were found in the introns 1, 2 and
3 and the −4−10 kb upstream region of transcriptional
start site (data not shown). The identification of these
sites support our interpretation that IL-4 mediated
STAT6 signaling may regulate the transcription of
MAL.
In this study, we clearly demonstrated that IL-4 me-
diates MAL expression in human CD3+ T cells, lead-
ing to the hypothesis that MAL might be involved in
Th2 differentiation. Studies of MAL mRNA expres-
sion in various leukemic T-cell lines, as well as in ma-
ture T cell clones, support its role in the intermediate
and late stages of differentiation. 3 Since a previous
study showed that committed Th1 and Th2 cells have
distinct patterns of membrane compartmentalization
into lipid rafts,25 it is reasonable to speculate that the
role of MAL may be to regulate the differential raft
conformation. In our study of Th2 polarized cells ,
marked upregulation of MAL was not observed when
compared to Th1 polarized cells, even though the po-
larized Th2 cells had been cultured in the presence of
IL-4. These data suggested that MAL was not in-
volved in the last stage of Th2 polarization of cord
blood cells under our experimental conditions. Fur-
ther studies of different conditions, such as the use of
T cell clones, are needed to clarify the role of MAL in
Th2 differentiation．
The TCR has a multi-subunit structure composed
of the polymorphic αβ heterodimer and the invariant
CD3 γ, δ, ε and ζ chains. All components of CD3 com-
plex possess the immune receptor tyrosine-based ac-
tivation motif ( ITAM). Phosphorylation of tyrosine
residues within the ITAM motif is critical for TCR sig-
nal transduction. Recent studies point to the impor-
tance of lipid rafts for the formation and stabilization
of the TCR signaling complexes. Specifically, T cell
activation leads to the recruitment of activated TCR
and associated signal transducing molecules in the
lipid rafts.26 The integrity of lipid rafts is a prerequi-
site for efficient T cell receptor signal transduction.27
Most of the phosphorylated CD3ζ accumulates into
the GEM microdomains after T cell activation.19 The
compartmentalization of MAL into GEM microdo-
mains suggests that MAL may also be an important
component for T cell signal transduction. The con-
comitant upregulation of CD3ζ and MAL that occurs
during exogenous expression of MAL in primary T
cells further suggests the possible involvement of
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MAL in modulating T cell receptor signaling.
Considering that IL-4 mediates MAL expression,
we can speculate that other allergens such as Japa-
nese cider pollen, may also upregulate MAL expres-
sion in antigen specific IgE (+) subjects. Further stud-
ies of the expression levels of MAL after stimulation
with other antigens should confirm this hypothesis.
Taken together, MAL may be involved in the patho-
physiology of allergic diseases by modifying the Th2
immune response in antigen specific IgE (+) individu-
als．
Differential expression profiling of genes as it re-
lates to patients with atopic diseases has been re-
ported11 and is expected to become a diagnostic tool
in the near future . Our studies show that 1) MAL
mRNA is upregulated in cells after addition of mite
extracts and 2) that the upregulation of MAL corre-
lates closely with anti-mite specific IgE and reflects
increased secretion of IL-4. These observations sup-
port the usefulness of examiningMAL expression lev-
els in both in vitro analysis of allergic responses, as
well as in diagnosis and detailed characterization of
allergic diseases.
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